[HTML][HTML] Evidence-based prevention of Alzheimer's disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised …
JT Yu, W Xu, CC Tan, S Andrieu, J Suckling… - Journal of Neurology …, 2020 - jnnp.bmj.com
Background Evidence on preventing Alzheimer's disease (AD) is challenging to interpret
due to varying study designs with heterogeneous endpoints and credibility. We completed a …
due to varying study designs with heterogeneous endpoints and credibility. We completed a …
Evidence-based prevention of Alzheimer's disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled …
JT Yu, W Xu, CC Tan, S Andrieu, J Suckling… - Journal of Neurology …, 2020 - europepmc.org
Background Evidence on preventing Alzheimer's disease (AD) is challenging to interpret
due to varying study designs with heterogeneous endpoints and credibility. We completed a …
due to varying study designs with heterogeneous endpoints and credibility. We completed a …
[HTML][HTML] Evidence-based prevention of Alzheimer's disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised …
JT Yu, W Xu, CC Tan, S Andrieu, J Suckling… - Journal of Neurology …, 2020 - jnnp.bmj.com
Background Evidence on preventing Alzheimer's disease (AD) is challenging to interpret
due to varying study designs with heterogeneous endpoints and credibility. We completed a …
due to varying study designs with heterogeneous endpoints and credibility. We completed a …
Evidence-based prevention of Alzheimer's disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled …
JT Yu, W Xu, CC Tan, S Andrieu, J Suckling… - 2020 - cabidigitallibrary.org
Abstract Background: Evidence on preventing Alzheimer's disease (AD) is challenging to
interpret due to varying study designs with heterogeneous endpoints and credibility. We …
interpret due to varying study designs with heterogeneous endpoints and credibility. We …
Evidence-Based Prevention of Alzheimer's Disease: Systematic Review and Meta-Analysis of 243 Observational Prospective Studies and 153 Randomized Controlled …
JT Yu, W Xu, CC Tan, S Andrieu, J Suckling… - 2019 - scholarbank.nus.edu.sg
Evidence-Based Prevention of Alzheimer's Disease: Systematic Review and Meta-Analysis of
243 Observational Prospective Studies and 153 Randomized Controlled Trials …
243 Observational Prospective Studies and 153 Randomized Controlled Trials …
Evidence-based prevention of Alzheimer's disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled …
JT Yu, W Xu, CC Tan, S Andrieu… - Journal of Neurology …, 2020 - hal.insa-toulouse.fr
Background Evidence on preventing Alzheimer's disease (AD) is challenging to interpret
due to varying study designs with heterogeneous endpoints and credibility. We completed a …
due to varying study designs with heterogeneous endpoints and credibility. We completed a …
Evidence-based prevention of Alzheimer's disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled …
JT Yu, W Xu, CC Tan, S Andrieu… - Journal of …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Evidence on preventing Alzheimer's disease (AD) is challenging to interpret
due to varying study designs with heterogeneous endpoints and credibility. We completed a …
due to varying study designs with heterogeneous endpoints and credibility. We completed a …
[HTML][HTML] Evidence-based prevention of Alzheimer's disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised …
JT Yu, W Xu, CC Tan, S Andrieu… - Journal of Neurology …, 2020 - ncbi.nlm.nih.gov
Background Evidence on preventing Alzheimer's disease (AD) is challenging to interpret
due to varying study designs with heterogeneous endpoints and credibility. We completed a …
due to varying study designs with heterogeneous endpoints and credibility. We completed a …
Evidence-based prevention of Alzheimer's disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled …
JT Yu, W Xu, CC Tan, S Andrieu, J Suckling… - 2020 - repository.cam.ac.uk
BACKGROUND: Evidence on preventing Alzheimer's disease (AD) is challenging to
interpret due to varying study designs with heterogeneous endpoints and credibility. We …
interpret due to varying study designs with heterogeneous endpoints and credibility. We …
Evidence-Based Prevention of Alzheimer's Disease: Systematic Review and Meta-Analysis of 243 Observational Prospective Studies and 153 Randomized Controlled …
JT Yu, W Xu, CC Tan, S Andrieu, J Suckling… - 2019 - papers.ssrn.com
Background: Evidence on preventing Alzheimer's disease (AD) is challenging to interpret
due to varying study designs with heterogeneous endpoints and credibility. We completed a …
due to varying study designs with heterogeneous endpoints and credibility. We completed a …